日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy.

开发具有不同生物学特性的新型人源抗OX-40单克隆抗体,作为癌症治疗的工具

Rapuano Lembo Rosa, Passariello Margherita, Manna Lorenzo, Froechlich Guendalina, Belardo Martina, Nicosia Alfredo, Sasso Emanuele, De Lorenzo Claudia

A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.

一种新型人源抗FV单克隆抗体作为诊断和凝血抑制方法的潜在工具

Passariello Margherita, Rapuano Lembo Rosa, Manna Lorenzo, Miele Ciro, Merlino Antonello, Mazzaccara Cristina, Leonardi Antonio, De Lorenzo Claudia

Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays

比较分析一种针对SARS-CoV-2 Spike-RBD的人源中和单克隆抗体与Cilgavimab和Tixagevimab对Omicron变异株的中和和检测效力

Passariello, Margherita; Esposito, Speranza; Manna, Lorenzo; Rapuano Lembo, Rosa; Zollo, Immacolata; Sasso, Emanuele; Amato, Felice; De Lorenzo, Claudia